CEL-SCI CORPORATION Operating Income
CEL-SCI CORPORATION (CVM) reported Operating Income of -$5.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- CEL-SCI CORPORATION operating income (loss) for the quarter ending 2026-06-30 was -$5.56M.
- CEL-SCI CORPORATION operating income (loss) for the quarter ending 2026-03-31 was -$5.33M.
- CEL-SCI CORPORATION operating income (loss) for the quarter ending 2025-12-31 was -$5.37M.
- CEL-SCI CORPORATION operating income (loss) for the quarter ending 2025-09-30 was -$6.03M.
- CEL-SCI CORPORATION operating income (loss) for fiscal 2025 was -$24.81M.
- CEL-SCI CORPORATION operating income (loss) for fiscal 2024 was -$26.35M.
- CEL-SCI CORPORATION operating income (loss) for fiscal 2023 was -$31.48M.
- CEL-SCI CORPORATION operating income (loss) for fiscal 2022 was -$36.06M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.56M 10-Q · filed 2026-08-14 | -$10.88M derived: sum of 2 quarters · filed 2026-08-14 | -$16.25M 10-Q · filed 2026-08-14 | -$22.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$5.33M 10-Q · filed 2026-05-15 | -$10.69M 10-Q · filed 2026-05-15 | -$16.73M derived: sum of 3 quarters · filed 2026-05-15 | -$22.22M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$5.37M 10-Q · filed 2026-02-17 | -$11.40M derived: sum of 2 quarters · filed 2026-02-17 | -$16.89M derived: sum of 3 quarters · filed 2026-08-14 | -$23.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-09-30 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$11.52M derived: sum of 2 quarters · filed 2026-08-14 | -$17.92M derived: sum of 3 quarters · filed 2026-08-14 | -$24.81M 10-K · filed 2025-12-29 | ||||
| 2025-06-30 | -$5.49M 10-Q · filed 2026-08-14 | -$11.88M derived: sum of 2 quarters · filed 2026-08-14 | -$18.78M 10-Q · filed 2026-08-14 | -$24.90M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$6.39M 10-Q · filed 2026-05-15 | -$13.29M 10-Q · filed 2026-05-15 | -$19.41M derived: sum of 3 quarters · filed 2026-05-15 | -$26.08M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$6.89M 10-Q · filed 2026-02-17 | -$13.01M derived: sum of 2 quarters · filed 2026-02-17 | -$19.68M derived: sum of 3 quarters · filed 2026-02-17 | -$26.76M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | -$6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$12.79M derived: sum of 2 quarters · filed 2025-12-29 | -$19.87M derived: sum of 3 quarters · filed 2025-12-29 | -$26.35M 10-K · filed 2025-12-29 | ||||
| 2024-06-30 | -$6.67M 10-Q · filed 2025-08-14 | -$13.75M derived: sum of 2 quarters · filed 2025-08-14 | -$20.23M 10-Q · filed 2025-08-14 | -$27.70M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$7.08M 10-Q · filed 2025-05-14 | -$13.56M 10-Q · filed 2025-05-14 | -$21.03M derived: sum of 3 quarters · filed 2025-05-14 | -$29.21M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$6.49M 10-Q · filed 2025-02-14 | -$13.95M derived: sum of 2 quarters · filed 2025-02-14 | -$22.14M derived: sum of 3 quarters · filed 2025-02-14 | -$30.31M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | -$7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | -$15.65M derived: sum of 2 quarters · filed 2025-01-13 | -$23.83M derived: sum of 3 quarters · filed 2025-01-13 | -$31.48M 10-K · filed 2025-01-13 | ||||
| 2023-06-30 | -$8.18M 10-Q · filed 2024-08-14 | -$16.36M derived: sum of 2 quarters · filed 2024-08-14 | -$24.01M 10-Q · filed 2024-08-14 | -$32.96M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$8.18M 10-Q · filed 2024-05-15 | -$15.83M 10-Q · filed 2024-05-15 | -$24.77M derived: sum of 3 quarters · filed 2024-05-15 | -$33.49M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$7.65M 10-Q · filed 2024-02-14 | -$16.60M derived: sum of 2 quarters · filed 2024-02-14 | -$25.32M derived: sum of 3 quarters · filed 2024-02-14 | -$34.87M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | -$8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$17.67M derived: sum of 2 quarters · filed 2023-12-21 | -$27.22M derived: sum of 3 quarters · filed 2023-12-21 | -$36.06M 10-K · filed 2023-12-21 | ||||
| 2022-06-30 | -$8.72M 10-Q · filed 2023-08-10 | -$18.27M derived: sum of 2 quarters · filed 2023-08-10 | -$27.11M 10-Q · filed 2023-08-10 | -$35.59M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$9.55M 10-Q · filed 2023-05-12 | -$18.40M 10-Q · filed 2023-05-12 | -$26.87M derived: sum of 3 quarters · filed 2023-05-12 | -$37.33M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$8.84M 10-Q · filed 2023-02-14 | -$17.32M derived: sum of 2 quarters · filed 2023-02-14 | -$27.77M derived: sum of 3 quarters · filed 2023-02-14 | -$36.31M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | -$8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | -$18.93M derived: sum of 2 quarters · filed 2022-12-27 | -$27.46M derived: sum of 3 quarters · filed 2022-12-27 | -$36.19M 10-K · filed 2022-12-27 | ||||
| 2021-06-30 | -$10.46M 10-Q · filed 2022-08-12 | -$18.99M derived: sum of 2 quarters · filed 2022-08-12 | -$27.72M 10-Q · filed 2022-08-12 | -$36.17M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$8.53M 10-Q · filed 2022-05-13 | -$17.26M 10-Q · filed 2022-05-13 | -$25.71M derived: sum of 3 quarters · filed 2022-05-13 | -$32.67M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$8.73M 10-Q · filed 2022-02-11 | -$17.18M derived: sum of 2 quarters · filed 2022-02-11 | -$24.14M derived: sum of 3 quarters · filed 2022-02-11 | -$30.86M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-09-30 | -$8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | -$15.41M derived: sum of 2 quarters · filed 2021-12-21 | -$22.13M derived: sum of 3 quarters · filed 2021-12-21 | -$28.99M 10-K · filed 2021-12-21 | ||||
| 2020-06-30 | -$6.97M 10-Q · filed 2021-08-13 | -$6.91M 10-Q/A · filed 2020-08-11 | -$13.68M derived: sum of 2 quarters · filed 2021-08-13 | -$20.54M 10-Q · filed 2021-08-13 | -$20.37M 10-Q/A · filed 2020-08-11 | -$26.18M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$6.72M 10-Q · filed 2021-05-17 | -$6.66M 10-Q · filed 2020-05-08 | -$13.57M 10-Q · filed 2021-05-17 | -$13.46M 10-Q · filed 2020-05-08 | -$19.22M derived: sum of 3 quarters · filed 2021-05-17 | -$24.43M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$6.86M 10-Q · filed 2021-02-12 | -$6.80M 10-Q · filed 2020-02-10 | -$12.50M derived: sum of 2 quarters · filed 2021-02-12 | -$17.71M derived: sum of 3 quarters · filed 2021-02-12 | -$22.02M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-09-30 | -$5.64M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | -$10.85M derived: sum of 2 quarters · filed 2020-12-31 | -$15.16M derived: sum of 3 quarters · filed 2020-12-31 | -$20.20M 10-K · filed 2020-12-29 | ||||
| 2019-06-30 | -$5.21M 10-Q/A · filed 2020-12-31 | -$9.52M derived: sum of 2 quarters · filed 2020-12-31 | -$14.55M 10-Q/A · filed 2020-12-31 | -$18.08M derived: sum of 4 quarters · filed 2020-12-31 | ||||
| 2019-03-31 | -$4.31M 10-Q/A · filed 2020-12-30 | -$9.34M 10-Q/A · filed 2020-12-30 | -$12.87M derived: sum of 3 quarters · filed 2020-12-30 | -$16.96M derived: sum of 4 quarters · filed 2020-12-30 | ||||
| 2018-12-31 | -$5.03M 10-Q/A · filed 2020-12-30 | -$8.57M derived: sum of 2 quarters · filed 2020-12-30 | -$12.65M derived: sum of 3 quarters · filed 2020-12-30 | -$16.88M derived: sum of 4 quarters · filed 2020-12-30 | ||||
| 2018-09-30 | -$3.53M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | -$7.62M derived: sum of 2 quarters · filed 2019-12-23 | -$11.84M derived: sum of 3 quarters · filed 2019-12-23 | -$16.77M 10-K/A · filed 2019-12-23 | ||||
| 2018-06-30 | -$4.09M 10-Q · filed 2019-08-14 | -$4.07M 10-Q · filed 2018-08-14 | -$8.31M derived: sum of 2 quarters · filed 2019-08-14 | -$13.24M 10-Q · filed 2019-08-14 | -$13.19M 10-Q · filed 2018-08-14 | -$17.04M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$4.22M 10-Q · filed 2019-05-14 | -$4.21M 10-Q · filed 2018-05-15 | -$9.15M 10-Q · filed 2019-05-14 | -$9.12M 10-Q · filed 2018-05-15 | -$12.96M derived: sum of 3 quarters · filed 2019-05-14 | -$17.72M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$4.93M 10-Q · filed 2019-02-14 | -$4.91M 10-Q · filed 2018-02-12 | -$8.73M derived: sum of 2 quarters · filed 2019-02-14 | -$13.49M derived: sum of 3 quarters · filed 2019-02-14 | -$21.40M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2017-09-30 | -$3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | -$8.56M derived: sum of 2 quarters · filed 2018-12-19 | -$16.47M derived: sum of 3 quarters · filed 2018-12-19 | -$21.41M 10-K · filed 2018-12-19 | -$21.34M 10-K · filed 2017-12-29 | |||
| 2017-06-30 | -$4.76M 10-Q · filed 2018-08-14 | -$5.24M 10-Q · filed 2017-08-09 | -$12.67M derived: sum of 2 quarters · filed 2018-08-14 | -$17.60M 10-Q · filed 2018-08-14 | -$19.03M 10-Q · filed 2017-08-09 | -$24.24M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$7.91M 10-Q · filed 2018-05-15 | -$8.38M 10-Q · filed 2017-05-10 | -$12.84M 10-Q · filed 2018-05-15 | -$13.80M 10-Q · filed 2017-05-10 | -$19.48M derived: sum of 3 quarters · filed 2018-05-15 | -$25.39M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$4.94M 10-Q · filed 2018-02-12 | -$5.41M 10-Q · filed 2017-02-09 | -$11.58M derived: sum of 2 quarters · filed 2018-02-12 | -$17.48M derived: sum of 3 quarters · filed 2018-02-12 | -$23.28M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2016-09-30 | -$6.64M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$12.54M derived: sum of 2 quarters · filed 2017-12-29 | -$18.34M derived: sum of 3 quarters · filed 2017-12-29 | -$23.65M 10-K · filed 2017-12-29 | -$25.55M 10-K · filed 2016-12-15 | |||
| 2016-06-30 | -$5.91M 10-Q/A · filed 2017-12-11 | -$6.38M 10-Q · filed 2016-08-09 | -$11.70M derived: sum of 2 quarters · filed 2017-12-11 | -$17.01M 10-Q/A · filed 2017-12-11 | -$18.44M 10-Q · filed 2016-08-09 | -$23.44M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2016-03-31 | -$5.80M 10-Q/A · filed 2017-12-11 | -$6.27M 10-Q · filed 2016-05-10 | -$11.10M 10-Q/A · filed 2017-12-11 | -$12.06M 10-Q · filed 2016-05-10 | -$17.54M derived: sum of 3 quarters · filed 2017-12-11 | -$25.74M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2015-12-31 | -$5.31M 10-Q/A · filed 2017-12-11 | -$5.78M 10-Q · filed 2016-02-09 | -$11.74M derived: sum of 2 quarters · filed 2017-12-11 | -$19.94M derived: sum of 3 quarters · filed 2017-12-11 | -$27.70M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2015-09-30 | -$6.43M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$14.64M derived: sum of 2 quarters · filed 2017-12-11 | -$22.39M derived: sum of 3 quarters · filed 2017-12-11 | -$32.39M 10-K/A · filed 2017-12-11 | -$34.30M 10-K · filed 2015-12-11 | |||
| 2015-06-30 | -$8.20M 10-Q · filed 2016-08-09 | -$15.96M derived: sum of 2 quarters · filed 2016-08-09 | -$25.96M 10-Q · filed 2016-08-09 | -$32.56M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2015-03-31 | -$7.76M 10-Q · filed 2016-05-10 | -$17.76M 10-Q · filed 2016-05-10 | -$24.36M derived: sum of 3 quarters · filed 2017-12-11 | -$31.26M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2014-12-31 | -$10.00M 10-Q · filed 2016-02-09 | -$16.60M derived: sum of 2 quarters · filed 2017-12-11 | -$23.50M derived: sum of 3 quarters · filed 2017-12-11 | -$29.73M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2014-09-30 | -$6.61M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$13.51M derived: sum of 2 quarters · filed 2017-12-11 | -$19.73M derived: sum of 3 quarters · filed 2017-12-11 | -$25.67M 10-K/A · filed 2017-12-11 | -$27.57M 10-K · filed 2014-12-23 | |||
| 2014-06-30 | -$6.90M 10-Q · filed 2015-08-07 | -$13.13M derived: sum of 2 quarters · filed 2015-08-07 | -$19.06M 10-Q · filed 2015-08-07 | -$24.13M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2014-03-31 | -$6.23M 10-Q · filed 2015-05-08 | -$12.16M 10-Q · filed 2015-05-08 | -$17.23M derived: sum of 3 quarters · filed 2015-12-11 | -$22.75M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-12-31 | -$5.93M 10-Q · filed 2015-02-06 | -$11.01M derived: sum of 2 quarters · filed 2015-12-11 | -$16.52M derived: sum of 3 quarters · filed 2015-12-11 | -$20.76M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-09-30 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$10.58M derived: sum of 2 quarters · filed 2015-12-11 | -$14.82M derived: sum of 3 quarters · filed 2015-12-11 | -$19.87M 10-K · filed 2015-12-11 | ||||
| 2013-06-30 | -$5.51M 10-Q · filed 2014-08-08 | -$9.75M derived: sum of 2 quarters · filed 2014-08-08 | -$14.80M 10-Q · filed 2014-08-08 | -$19.12M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2013-03-31 | -$4.24M 10-Q · filed 2014-05-12 | -$9.28M 10-Q · filed 2014-05-12 | -$13.61M derived: sum of 3 quarters · filed 2014-12-23 | -$17.82M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-12-31 | -$5.04M 10-Q · filed 2014-02-10 | -$9.37M derived: sum of 2 quarters · filed 2014-12-23 | -$13.58M derived: sum of 3 quarters · filed 2014-12-23 | -$17.84M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-09-30 | -$4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | -$8.54M derived: sum of 2 quarters · filed 2014-12-23 | -$12.80M derived: sum of 3 quarters · filed 2014-12-23 | -$17.24M 10-K · filed 2014-12-23 | ||||
| 2012-06-30 | -$4.21M 10-Q · filed 2013-08-09 | -$8.48M derived: sum of 2 quarters · filed 2013-08-09 | -$12.92M 10-Q · filed 2013-08-09 | -$16.65M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2012-03-31 | -$4.26M 10-Q · filed 2013-05-10 | -$8.71M 10-Q · filed 2013-05-10 | -$12.43M derived: sum of 3 quarters · filed 2013-12-27 | -$17.28M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-12-31 | -$4.44M 10-Q · filed 2013-02-08 | -$8.17M derived: sum of 2 quarters · filed 2013-12-27 | -$13.02M derived: sum of 3 quarters · filed 2013-12-27 | -$18.11M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-09-30 | -$3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$8.57M derived: sum of 2 quarters · filed 2013-12-27 | -$13.67M derived: sum of 3 quarters · filed 2013-12-27 | -$17.99M 10-K · filed 2013-12-27 | ||||
| 2011-06-30 | -$4.85M 10-Q · filed 2012-08-09 | -$9.94M derived: sum of 2 quarters · filed 2012-08-09 | -$14.26M 10-Q · filed 2012-08-09 | -$19.85M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2011-03-31 | -$5.10M 10-Q · filed 2012-05-10 | -$9.41M 10-Q · filed 2012-05-10 | -$15.01M derived: sum of 3 quarters · filed 2012-12-14 | -$18.40M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2010-12-31 | -$4.32M 10-Q · filed 2012-02-09 | -$9.91M derived: sum of 2 quarters · filed 2012-12-14 | -$13.30M derived: sum of 3 quarters · filed 2012-12-14 | |||||
| 2010-09-30 | -$5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | -$8.99M derived: sum of 2 quarters · filed 2012-12-14 | -$18.56M 10-K · filed 2012-12-14 | |||||
| 2010-06-30 | -$3.39M 10-Q · filed 2011-08-09 | -$12.97M 10-Q · filed 2011-08-09 | ||||||
| 2009-09-30 | -$12.02M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |